An Innovative Sunlight-Driven Device for Photocatalytic Drugs Degradation: from laboratory- to real-Scale Application. A First Step Toward Vulnerable Communities

Freshwater represents one of the most precious resources on the planet, so it is fundamental to preserve it. In this work, an innovative sunlight-driven device composed of bismuth oxybromide (BiOBr) grown on a material derived from natural sources, i.e., Lightweight Expanded Clay Aggregates (LECA), is developed to clean surface waters under natural solar light irradiation. For this purpose, the photodegradation of two non-steroidal anti-inflammatory drugs, ibuprofen, and diclofenac, is investigated under varying operative conditions. Laboratory- and real-scale experiments reveal that the fabricated floating BiOBr/LECA photocatalyst fully degrades diclofenac, whereas limited abatement of ibuprofen is observed. Based on the identification of specific transformation products (TPs) during the degradation, this behavior seems to be strongly related to the different structures of the two drugs. In fact, the main TP produced during diclofenac degradation derives from dechlorination and ring condensation: this type of photocatalytic degradation pathway is generally favored over the CC bonds's cleavage, which is a unique possibility for IBU abatement. Moreover, the potential partial adsorption of these species on the photocatalyst's active sites can cause their deactivation. Finally, reusability tests demonstrate the high stability of the floating composite. An innovative floating photocatalyst, based on BiOBr grown on LECA, is fabricated and tested in the degradation of two common non-steroidal anti-inflammatory drugs, diclofenac, and ibuprofen, under solar light irradiation in different conditions. The very promising results pave the way for BiOBr/LECA as an alternative to traditional materials for the effective removal of pharmaceutical drugs from water. image